Publications by authors named "Lori M Minasian"

86Publications

Chemotherapy-induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design.

Cancer 2020 Aug 11. Epub 2020 Aug 11.

Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.33108DOI Listing
August 2020

Age-related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B).

Acta Ophthalmol 2020 Jul 23. Epub 2020 Jul 23.

Department of Urology, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aos.14538DOI Listing
July 2020

Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.

Cancer 2020 Jun 1;126(11):2687-2693. Epub 2020 Apr 1.

Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32765DOI Listing
June 2020

What Keeps Patients Out of Clinical Trials?

JCO Oncol Pract 2020 03 19;16(3):125-127. Epub 2020 Feb 19.

Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.19.00735DOI Listing
March 2020

Breast cancer risk prediction models and subsequent tumor characteristics.

Breast Cancer 2020 Jul 13;27(4):662-669. Epub 2020 Feb 13.

Division of Cancer Prevention, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-020-01060-9DOI Listing
July 2020

Clinical Outcome Assessments Toolbox for Radiopharmaceuticals.

Front Oncol 2019 10;9:1028. Epub 2019 Oct 10.

Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.01028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795707PMC
October 2019

Long-Term Effects of Finasteride on Prostate Cancer Mortality.

N Engl J Med 2019 01;380(4):393-394

CHRISTUS Santa Rosa Hospital Medical Center, San Antonio, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1809961DOI Listing
January 2019

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study.

J Clin Oncol 2018 Sep 21:JCO2018786624. Epub 2018 Sep 21.

Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Supriya G. Mohile, Karen M. Mustian, Annalynn M. Williams, Allison Magnuson, and Gary R. Morrow, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Oxana Palesh, Stanford Cancer Center, Stanford, CA; Ann M. O'Mara and Lori M. Minasian, National Cancer Institute (NCI), National Institutes of Health, Rockville, MD; Jodi Geer, Metro Minnesota NCI Community Oncology Research Program (NCORP), Saint Louis Park, MN; Shaker R. Dakhil, Wichita NCORP, Wichita, KS; and Judith O. Hopkins, Southeast Clinical Oncology Research Consortium NCORP, Winston-Salem, NC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.6624
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.6624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225503PMC
September 2018

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

J Clin Oncol 2018 Sep 11:JCO2018788620. Epub 2018 Sep 11.

Ethan Basch, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Bryce B. Reeve, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Ethan Basch, Lauren J. Rogak, Mary C. Shaw, Narre Heon, and Martin R. Weiser, Memorial Sloan Kettering Cancer Center, New York, NY; Amylou C. Dueck and Brenda Ginos, Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ; Sandra A. Mitchell, Lori M. Minasian, and Andrea M. Denicoff, National Cancer Institute, Rockville, MD; Jennifer K. Wind, Harvey J. Mamon, and Deborah Schrag, Dana-Farber/Partners CancerCare, Boston, MA; Qian Shi, Garth D. Nelson, and Jeffrey P. Meyers, Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; George J. Chang, University of Texas MD Anderson Cancer Center, Houston, TX; Tatjana Kolevska, Kaiser Permanente Vallejo Medical Center, Vallejo, CA; and Deborah Watkins Bruner, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.8620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209091PMC
September 2018

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.

Cancer Med 2018 May 30. Epub 2018 May 30.

Division of Hematology, Oncology, and Blood and Bone Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051159PMC
May 2018

Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib.

Cancer Invest 2017 Aug 10;35(7):484-489. Epub 2017 Jul 10.

d Herbert Irving Comprehensive Cancer Center, Department of Medicine , Columbia University , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2017.1340479DOI Listing
August 2017

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.

J Clin Oncol 2017 Jul 11;35(20):2329-2337. Epub 2017 Apr 11.

Goli Samimi, Charlisse F. Caga-anan, Michael Dean, Leah E. Mechanic, Lori M. Minasian, and Mark E. Sherman, National Cancer Institute; Lawrence C. Brody, National Human Genome Research Institute, Bethesda, MD; Marcus Q. Bernardini, Stephanie Lheureux, Patricia A. Shaw, Princess Margaret Cancer Centre, Toronto, Ontario; Janice S. Kwon, University of British Columbia; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Ian G. Campbell, Paul A. James, Masataka Takenaka, and David D. Bowtell, Peter MacCallum Cancer Centre; David D. Bowtell, University of Melbourne, Melbourne, Victoria; Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Michael Friedlander, The Prince of Wales Hospital; Susan J. Ramus, University of New South Wales; Susan J. Ramus and David D. Bowtell, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Fergus J. Couch, Mayo Clinic, Rochester, MN; Joanne A. de Hullu and Marline G. Harmsen, Radboud University Medical Center, Nijmegen, the Netherlands; Susan M. Domchek and Ronny Drapkin, University of Pennsylvania, Philadelphia; Phuong L. Mai, Magee-Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; Heather Spencer Feigelson, Kaiser Permanente Institute for Health Research, Denver, CO; Mia M. Gaudet, American Cancer Society, Atlanta, GA; Karen Hurley and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mark E. Robson, Weill Cornell Medical College, New York, NY; Felicitas Lacbawan, Quest Diagnostics Nichols Institute, San Juan Capistrano; Thomas P. Slavin, City of Hope, Duarte, CA; Evan R. Myers, Duke University Medical Center, Durham, NC; Lisa F. Rezende, FORCE: Facing Our Risk of Cancer Empowered, Tampa; Mark E. Sherman, Mayo Clinic, Jacksonville, FL; and Elizabeth M. Swisher, University of Washington Medical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501360PMC
July 2017

Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?

Cancer 2017 05 23;123(10):1699-1702. Epub 2017 Mar 23.

Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30525DOI Listing
May 2017

The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.

Gynecol Oncol 2016 Dec 30;143(3):611-616. Epub 2016 Sep 30.

Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.09.026DOI Listing
December 2016

Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.

J Natl Cancer Inst 2016 12 26;108(12). Epub 2016 Aug 26.

SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA (JMU, CT, CMT, PJG, WEB); Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX (IMTJr); Columbia University, New York, NY (JDW, DLH); Fred Hutchinson Cancer Research Center, Seattle, WA (SDR); Division of Cancer Prevention, U.S. National Cancer Institute, Rockville, MD (LMM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241895PMC
December 2016

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.

J Clin Oncol 2016 09 20;34(25):3014-22. Epub 2016 Jun 20.

Dawn L. Hershman, Jason D. Wright, and Danielle Awad, Columbia University Medical Center, New York, NY; Cathee Till, Scott D. Ramsey, and Joseph Unger, Fred Hutchinson Cancer Research Center; William E. Barlow, University of Washington, Seattle, WA; and Lori M. Minasian, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.2346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012713PMC
September 2016

Reducing Overtreatment in Gynecologic Oncology: The Case for Less in Endometrial and Ovarian Cancer.

Front Oncol 2016 9;6:118. Epub 2016 May 9.

The Division of Cancer Prevention, The National Cancer Institute, National Institutes of Health , Bethesda, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2016.00118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860790PMC
May 2016

Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress.

Free Radic Biol Med 2016 06 22;95:349-56. Epub 2016 Mar 22.

Division of Nutritional Sciences, Cornell University, 209 Savage Hall, Ithaca, NY 14853, USA; Department of Healthcare Policy and Research, Division of Biostatistics and Epidemiology, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2016.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867301PMC
June 2016

Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.

Semin Oncol 2015 Oct 10;42(5):748-63. Epub 2015 Jul 10.

Department of Human Oncology, Pittsburgh Campus of Temple University School of Medicine, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593316PMC
October 2015

Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

J Clin Oncol 2015 Nov 31;33(33):3961-7. Epub 2015 Aug 31.

Jennifer A. Ligibel and Elizabeth S. Frank, Dana-Farber Cancer Institute, Boston, MA; Catherine M. Alfano, Elvan C. Daniels, and Kevin D. Stein, American Cancer Society, Atlanta, GA; Dawn Hershman, Columbia University; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Rachel M. Ballard, National Institutes of Health; Worta McCaskill-Stevens and Lori M. Minasian, National Cancer Institute, Bethesda, MD; Suanna S. Bruinooge and Laura A. Levit, American Society of Clinical Oncology, Alexandria, VA; Kerry S. Courneya, University of Alberta, Edmonton, Alberta; Pamela J. Goodwin, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada; Wendy Demark-Wahnefried, University of Alabama at Birmingham, Birmingham, AL; Melinda L. Irwin, Yale School of Public Health, New Haven, CT; Mark A. O'Rourke, Greenville Hospital System, Greenville, SC; John P. Pierce, University of California San Diego Moores Cancer Center, San Diego, CA; and Cynthia A. Thomson, University of Arizona, Tucson, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1440DOI Listing
November 2015

Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.

J Clin Oncol 2015 06 4;33(17):1910-7. Epub 2015 May 4.

Dawn L. Hershman, Katherine D. Crew, Danielle Awad, and Heather Greenlee, Columbia University Medical Center, New York, NY; Joseph M. Unger, Danika L. Lew, and Cathee Till, Southwest Oncology Group Statistical Center; Joseph M. Unger, Julie Gralow, Danika L. Lew, Cathee Till, and Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Lori M. Minasian, National Cancer Institute, Bethesda, MD; James L. Wade III, Central Illinois Community Clinical Oncology Program/Cancer Care Specialists of Central Illinois, Decatur, IL; and Frank L. Meyskens, University of California at Irvine, Chao Family Comprehensive Cancer Center, Orange, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.59.5595
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.5595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451174PMC
June 2015

Multilevel modeling and value of information in clinical trial decision support.

BMC Syst Biol 2014 Dec 24;8. Epub 2014 Dec 24.

Computer Science and Artificial Intelligence Laboratory and Program in Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12918-014-0140-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304628PMC
December 2014

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

J Natl Cancer Inst 2014 Sep 29;106(9). Epub 2014 Sep 29.

: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC (EB, BBR, AVB); Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC (EB, BBR, AVB); Department of Epidemiology and Biostatistics, Health Outcomes Research Group (EB, LS, LR) and Department of Psychiatry and Behavioral Sciences (JH, TMA), Memorial Sloan Kettering Cancer Center, New York, NY; Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences (SAM, SBC), Division of Cancer Prevention (LMM), NCTN Clinical Trials Operations, Cancer Therapy Evaluation Program (AD), Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention (AMO, DSG, JK), and Investigational Drug Branch, Cancer Therapy Evaluation Program (AC), National Cancer institute, Bethesda, MD;Division of Health Sciences Research, College of Medicine, Mayo Clinic - Arizona, Scottsdale, AZ (ACD); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (TRM, CSC); Patient Advocate, New York, NY (DBP); Department of Medicine, Duke Center for Learning HealthCare, Duke Cancer Research Program, Duke University, Durham, NC (APA); Nell Hodgson Woodruff School of Nursing, Winship Cancer Institute of Emory University, Emory University, Atlanta, GA (DWB); Mayo Clinic - Rochester, Rochester, MN (JAS); SemanticBits LLC, Herndon, VA (RC, PB); Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA (AB); Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (DS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200059PMC
September 2014

Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

J Natl Cancer Inst 2014 Jul 8;106(7). Epub 2014 Jul 8.

Affiliations of authors: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC (BBR, EB); Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (SAM); Division of Cancer Prevention, National Cancer Institute, Bethesda, MD (LMM and AMO); Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (AMD); Division of Health Sciences Research, Mayo Clinic, Scottsdale, AZ (ACD); Feinberg School of Medicine, Northwestern University, Chicago, IL (DC); Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA (CMR, DWB); Department of General Oncology, MD Anderson Cancer Center, Houston, TX (MJF); Mayo Clinic Breast SPORE, Rochester, MN (CCh); Department of Psychological Research, The Netherlands Cancer Institute, Amsterdam, The Netherlands (NKA); Quality of Life Department, European Organization for the Research and Treatment of Cancer, Brussels, Belgium (CCo).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/106/7/dju132.full.pdf
Web Search
http://www.cancer.gov/about-nci/organization/ccct/steering-c
Web Search
http://www.cancer.gov/about-nci/organization/ccct/steering-c
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju129
Publisher Site
http://dx.doi.org/10.1093/jnci/dju129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110472PMC
July 2014

Organizational and physician factors associated with patient enrollment in cancer clinical trials.

Clin Trials 2014 Oct 5;11(5):565-75. Epub 2014 Jun 5.

Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774514536000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156916PMC
October 2014

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

J Natl Cancer Inst 2014 Mar 22;106(3):djt456. Epub 2014 Feb 22.

Affiliations of authors: Cancer Prevention Program (ARK) and SWOG Statistical Center (AKD, CMT, PJG), Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology (ARK, GEG) and Department of Environmental Health (GEG), University of Washington, Seattle, WA; University of Missouri, Research Reactor Center, Columbia, MO (JSM); Harry S. Truman Memorial Veterans Hospital, Columbia, MO (JSM); Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX (IMT); Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA (FLM); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, HLP); Moores Cancer Center, University of California San Diego, San Diego, CA (SML); Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH (EAK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975165PMC
March 2014

Phase III prostate cancer chemoprevention trials.

Recent Results Cancer Res 2014 ;202:73-7

Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-45195-9_9DOI Listing
May 2014

Long-term survival of participants in the prostate cancer prevention trial.

N Engl J Med 2013 Aug;369(7):603-10

University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1215932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141537PMC
August 2013

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

J Natl Cancer Inst 2013 Aug 10;105(15):1132-41. Epub 2013 Jul 10.

Department of Internal Medicine, Division of Cancer Prevention and Control, The Ohio State University College of Medicine, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735464PMC
August 2013

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment.

Support Care Cancer 2013 Jun 12;21(6):1525-50. Epub 2013 Jan 12.

Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, NE #254, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-012-1688-0
Publisher Site
http://dx.doi.org/10.1007/s00520-012-1688-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299699PMC
June 2013

Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.

Contemp Clin Trials 2013 Mar 5;34(2):320-5. Epub 2013 Jan 5.

Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, NC 27599-7411, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2012.12.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594576PMC
March 2013

Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.

J Oncol Pract 2012 Sep 1;8(5):287-91. Epub 2012 May 1.

University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7590, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2011.000507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439228PMC
September 2012

Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.

Contemp Clin Trials 2012 Sep 8;33(5):933-41. Epub 2012 Jun 8.

Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, NC 27599-7411, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2012.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408810PMC
September 2012

Accrual to clinical trials: let's look at the physicians.

J Natl Cancer Inst 2011 Mar 11;103(5):357-8. Epub 2011 Feb 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr018DOI Listing
March 2011

A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Nutr Cancer 2010 ;62(7):896-918

Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2010.509833DOI Listing
January 2011

Learning from experience.

Oncologist 2009 May 5;14(5):476-7. Epub 2009 May 5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-0073DOI Listing
May 2009

Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with 'what-ifs'.

Pharmacogenomics 2009 Jan;10(1):137-47

CEDD, Global Regulatory Affairs, Neurology & Pharmacogenetics, GlaxoSmithKline, Greenford Road, Greenford, Middlesex, UB6 OHE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.10.1.137DOI Listing
January 2009

Health-related quality of life and symptom management research sponsored by the National Cancer Institute.

J Clin Oncol 2007 Nov;25(32):5128-32

Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7340, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.12.6672
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.12.6672DOI Listing
November 2007

Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Clin Trials 2005 ;2(5):436-42

Department of Clinical Cancer Prevention, Unit 1360, The University of Texas M D Anderson Cancer Center, Houston 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1191/1740774505cn111oaDOI Listing
January 2006

Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.

J Clin Oncol 2005 Jan;23(3):591-8

Division of Cancer Prevention, National Cancer Institute/NIH, 6130 Executive Blvd, Room EPN 2149, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.12.181DOI Listing
January 2005

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

N Engl J Med 2004 May;350(22):2239-46

Division of Urology, Department of Surgery, University of Texas Health Science Center at San Antonio, San Antonio, Tex, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa031918DOI Listing
May 2004

Prevention and early detection clinical trials: opportunities for primary care providers and their patients.

CA Cancer J Clin 2003 Mar-Apr;53(2):82-101

Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/canjclin.53.2.82DOI Listing
April 2003